ImmunoGen’s drug Elahere offers hope for ovarian cancer patients

ImmunoGen’s drug Elahere offers hope for ovarian cancer patients

Submitted by admin on May 17, 2023 - 10:50pm
Source: 
Clinical Trials Arena
News Tags: 
Immunogen
Elahere
clinical trials
platinum-resistant ovarian cancer
ovarian cancer
Headline: 
ImmunoGen’s drug Elahere offers hope for ovarian cancer patients
snippet: 

ImmunoGen has announced positive results from the Phase III MIRASOL trial of Elahere (mirvetuximab soravtansine-gynx) for platinum-resistant ovarian cancer patients with medium to high levels of folate receptor alpha.

Do Not Allow Advertisers to Use My Personal information